Literature DB >> 15210368

Evidence for the reactivity of fatty aldehydes released from oxidized plasmalogens with phosphatidylethanolamine to form Schiff base adducts in rat brain homogenates.

Sabrina Stadelmann-Ingrand1, Raymond Pontcharraud, Bernard Fauconneau.   

Abstract

The vinyl ether bond of plasmalogens could be among the first target of free radicals attack. Consequently, because of their location in the membranes of cells, plasmalogens represent a first shield against oxidative damages by protecting other macromolecules and are often considered as antioxidant molecules. However, under oxidative conditions their disruption leads to the release of fatty aldehydes. In this paper, we showed using gas chromatography-mass spectrometry (GC-MS) analyses that fatty aldehydes released from plasmalogens after oxidation (UV irradiation and Fe2+/ascorbate) of cerebral cortex homogenates can generate covalent modifications of endogenous macromolecules such as phosphatidylethanolamine (PE), like the very reactive and toxic malondialdehyde (MDA) and 4-hydroxynonenal (4-HNE). These newly formed Schiff base adducts could be responsible for deleterious effects on cells thus making the protective role of plasmalogens potentially questionable.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15210368     DOI: 10.1016/j.chemphyslip.2004.04.008

Source DB:  PubMed          Journal:  Chem Phys Lipids        ISSN: 0009-3084            Impact factor:   3.329


  22 in total

1.  Identification of novel bioactive aldehyde-modified phosphatidylethanolamines formed by lipid peroxidation.

Authors:  Lilu Guo; Zhongyi Chen; Venkataraman Amarnath; Sean S Davies
Journal:  Free Radic Biol Med       Date:  2012-08-04       Impact factor: 7.376

2.  Phosphatidylethanolamines modified by γ-ketoaldehyde (γKA) induce endoplasmic reticulum stress and endothelial activation.

Authors:  Lilu Guo; Zhongyi Chen; Brian E Cox; Venkataraman Amarnath; Raquel F Epand; Richard M Epand; Sean S Davies
Journal:  J Biol Chem       Date:  2011-03-25       Impact factor: 5.157

3.  Mouse brain plasmalogens are targets for hypochlorous acid-mediated modification in vitro and in vivo.

Authors:  Andreas Ullen; Günter Fauler; Harald Köfeler; Sabine Waltl; Christoph Nusshold; Eva Bernhart; Helga Reicher; Hans-Jörg Leis; Andrea Wintersperger; Ernst Malle; Wolfgang Sattler
Journal:  Free Radic Biol Med       Date:  2010-08-31       Impact factor: 7.376

4.  Oxidation of Plasmalogen, Low-Density Lipoprotein and RAW 264.7 Cells by Photoactivatable Atomic Oxygen Precursors.

Authors:  Max T Bourdillon; Benjamin A Ford; Ashley T Knulty; Colleen N Gray; Miao Zhang; David Ford; Ryan D McCulla
Journal:  Photochem Photobiol       Date:  2014 Mar-Apr       Impact factor: 3.421

5.  Plasmalogen deficiency in cerebral adrenoleukodystrophy and its modulation by lovastatin.

Authors:  Mushfiquddin Khan; Jaspreet Singh; Inderjit Singh
Journal:  J Neurochem       Date:  2008-06-07       Impact factor: 5.372

6.  Genetics and prospective therapeutic targets for Sjögren-Larsson Syndrome.

Authors:  William B Rizzo
Journal:  Expert Opin Orphan Drugs       Date:  2016-03-10       Impact factor: 0.694

Review 7.  Fatty aldehyde and fatty alcohol metabolism: review and importance for epidermal structure and function.

Authors:  William B Rizzo
Journal:  Biochim Biophys Acta       Date:  2013-09-12

8.  Low-concentration ozone reacts with plasmalogen glycerophosphoethanolamine lipids in lung surfactant.

Authors:  Kelly M Wynalda; Robert C Murphy
Journal:  Chem Res Toxicol       Date:  2010-01       Impact factor: 3.739

9.  Characterization of acrolein-glycerophosphoethanolamine lipid adducts using electrospray mass spectrometry.

Authors:  Karin A Zemski Berry; Robert C Murphy
Journal:  Chem Res Toxicol       Date:  2007-07-18       Impact factor: 3.739

Review 10.  Lipid peroxidation generates biologically active phospholipids including oxidatively N-modified phospholipids.

Authors:  Sean S Davies; Lilu Guo
Journal:  Chem Phys Lipids       Date:  2014-04-02       Impact factor: 3.329

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.